Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
1.3%
1w
1.3%
1m
37.0%
3m
51.7%
6m
62.8%
1y
126.1%
all
68.1%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

788 1.3%
492
845
Company Overview

Sales
873 Cr
Growth: -0.3%
Profit after Tax
235 Cr
Growth: 39.8%
Mid Cap
13,665 Cr
P/E: 58.2x
Industry P/E: 29.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 873
Growth -0.3%
EBITDA 33.3%
P/S 15.6x
Dividend 0.0%
P/E 58.2x
Book Value ₹ 60
PEG Ratio -191.3x
ROE 25.3%
P/B 13.1x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.